Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
Background. Recent studies have suggested that cell death might be involved in the pathophysiology of metabolic disorders. The cytokeratin 18 (CK18) fragment, as a cell death marker, plays an important role in nonalcoholic fatty liver disease (NAFLD). However, only a limited number of studies have f...
Saved in:
| Main Authors: | Lingling Qian, Lei Zhang, Liang Wu, Jing Zhang, Qichen Fang, Xuhong Hou, Qiongmei Gao, Huating Li, Weiping Jia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2020/5198359 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Miwa Kawanaka, et al.
Published: (2024-01-01) -
Expression of Cytokeratin (Ck) 7, Cytokeratin (Ck) 18, Carcinoembryonic Antigen (Cea) and Alpha Fetoprotein (Afp) In Liver Diseases
by: Shema, F.B.*, Adisa J.O.
Published: (2020-03-01) -
Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease
by: Magdalena Świderska, et al.
Published: (2017-01-01) -
Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
by: John Castle, et al.
Published: (2017-01-01) -
Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma
by: Ivković-Kapicl Tatjana, et al.
Published: (2012-01-01)